TRANSIL^® Plasma Protein Binding Kit

A ready-to-use kit to for rapid assessment of drugs candidates' binding to major plasma proteins HSA & AGP

A novel ready-to-use binding kit designed to assess the binding of drugs to plasma binding protein and mimic the physiological condition of the major plasma proteins human serum albumin (HSA) and a₁-acid glycoprotein (AGP). The affinity of a drug candidate to plasma proteins is a true measurement of the free fraction of a drug candidate in plasma.

Benefits

Fast, requiring only 2 minutes for incubation.
Accurate. Measures the affinity of the drug candidate to plasma proteins, a true measurement of the free fraction in plasma, capable of producing pharmacological effects.
Reliable with highly reproducible results, and robust correlation to equilibrium dialysis method (end-point measurement). Fully quality-controlled plasma protein binding estimates.
Relevant. Consists of a mixture of human serum albumin and a₁-acid glycoprotein (HSA:AGP = 24:1) a typical physiological ratio of the proteins.
Ready-to-use format plated in 96-well or ready-to-use tubes in strips of 8. Kit only requires addition of test material, 2-minute incubation, and quantification.
Flexible. Adaptable to automation.

Product Information

Product Number	Product Name	Format
TPB-0212-0096	Transil^® Plasma Protein Binding Kit	96-well plate
TPB-0212-1196	Transil^® Plasma Protein Binding Kit	96-well (strips)

TRANSIL® Plasma Protein Binding Kit

Benefits

Product Information

TRANSIL^® Plasma Protein Binding Kit